CLINICAL_TRIALS
trial_result
· 2016-11-25
Clinical Trial Update: Wound Fluid Protease Levels During Use of Novel Wound Dressing [Phase 4]
Summary
A Phase 4 clinical trial evaluated wound fluid protease levels during use of a novel wound dressing in venous stasis ulcers, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hollister Incorporated | Conditions: Venous Stasis Ulcers | Phase 4 | Status: COMPLETED | Results posted: 2016-11-25